Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
A tricyclic antidepressant (TCA) is an older class of medicine named for its three-ring chemical structure. TCAs increase signaling involving norepinephrine and serotonin by reducing their reuptake into nerve cells. They also affect histamine, muscarinic, and alpha-adrenergic receptors to varying degrees. These additional effects contribute to both clinical uses and side effects.
read more about tricyclic antidepressant ...TCAs are used to treat depression, particularly when other treatments are ineffective or unsuitable. Selected drugs are also prescribed for neuropathic pain, migraine prevention, insomnia, obsessive-compulsive disorder, or childhood enuresis. Approved and off-label uses differ among individual medicines. The choice depends on symptoms, other conditions, prior treatment, interactions, and overdose risk.
TCAs inhibit transporters that normally return norepinephrine and serotonin to presynaptic nerve cells. This increases the availability of these neurotransmitters within synapses. Many TCAs also block muscarinic, histamine H1, and alpha-1 adrenergic receptors. Their antidepressant benefit develops gradually even though transporter inhibition begins earlier.
Examples include amitriptyline, nortriptyline, imipramine, desipramine, clomipramine, and doxepin. Tertiary amine TCAs commonly have stronger serotonin-reuptake and anticholinergic effects, while secondary amines commonly act more strongly on norepinephrine reuptake. These patterns are general and do not replace drug-specific information. Individual TCAs differ in sedation, interactions, approved uses, and cardiac effects.
Common effects include dry mouth, constipation, blurred vision, urinary difficulty, drowsiness, weight gain, and dizziness when standing. TCAs can affect cardiac conduction and can cause dangerous arrhythmias, seizures, severe low blood pressure, or coma in overdose. Alcohol and other sedating or anticholinergic medicines can worsen adverse effects. Treatment requires careful dosing, suicide-risk monitoring, and avoidance of abrupt discontinuation without guidance.
Yes. They are less commonly selected first for depression because newer medicines tend to cause fewer serious adverse effects. TCAs remain useful for selected mood, pain, sleep, and neurological conditions.
Some effects on sleep or pain can appear earlier, but antidepressant improvement commonly takes several weeks. A prescriber assesses response, side effects, and dose over time.
TCAs can rapidly disrupt cardiac conduction, blood pressure, and the nervous system in overdose. Suspected overdose is a medical emergency even when early symptoms appear mild.
Stopping suddenly can cause nausea, headache, sleep disturbance, anxiety, or a return of symptoms. A gradual dose reduction is commonly used under prescriber guidance.
Tricyclic Antidepressants. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK557791/. Date Accessed August 6, 2026.
Tricyclic Antidepressant Toxicity. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK430931/. Date Accessed August 6, 2026.
Amitriptyline: MedlinePlus Drug Information. MedlinePlus. https://medlineplus.gov/druginfo/meds/a682388.html. Date Accessed August 6, 2026.
Clomipramine: MedlinePlus Drug Information. MedlinePlus. https://medlineplus.gov/druginfo/meds/a697002.html. Date Accessed August 6, 2026.
Imipramine: MedlinePlus Drug Information. MedlinePlus. https://medlineplus.gov/druginfo/meds/a682389.html. Date Accessed August 6, 2026.